Perth-based burns treatment company Clinical Cell Culture Ltd has entered into a supply agreement with pharmaceutical company CSL Ltd for the supply of Trypsin, a key component of the Company's ReCell tissue harvesting device.
News
>
28/09/2006 - 08:39
C3 signs $1m contract with CSL
28/09/2006 - 08:39
Related Data & Insights
-
-
Rank Company Revenue 10th Amcor $22,205.1m 12th CSL $20,075.4m 16th BlueScope Steel $18,053.9m 17th Macquarie Group $17,056.0m 1329 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Data & Insights
Mentioned Organisations
Related Articles
14 Apr 2021
Vaccine not a silver bullet: Morrison
Subscribe today for award-winning, unbiased and trusted journalism
Subscription OptionsX